Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1372937 | 0.87 | RAB9A (0.48) | RAB9AL3MBTL1NPC1TDP1ALDH1A1 | |
| SCHEMBL13385709 | 0.80 | PPARG (0.37) | L3MBTL1NPC1ALDH1A1LMNAMAPT | |
| SCHEMBL38933 | 0.79 | MGLL (0.47) | NPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL22357194 | 0.79 | MGLL (0.47) | NPC1ALDH1A1SMN1; SMN2LMNA | |
| Dioxane SCHEMBL11840291 | 0.78 | PPARG (0.41) | RAB9AL3MBTL1NPC1TDP1 | |
| Water SCHEMBL28237529 | 0.77 | MGLL (0.46) | NPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL27538597 | 0.77 | MGLL (0.46) | NPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL1426691 | 0.77 | ALDH1A1 (0.46) | RAB9AL3MBTL1NPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL15500021 | 0.77 | KMT2A (0.57) | RAB9AL3MBTL1NPC1ALDH1A1SMN1; SMN2 | |
| Oxirane SCHEMBL6474718 | 0.76 | CA2 (0.61) | RAB9ANPC1TDP1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170040543-A1 | ORGANIC SOLAR CELL AND MANUFACTURING METHOD THEREFOR | LG CHEM, LTD. (KR) | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170040543-A1 | ORGANIC SOLAR CELL AND MANUFACTURING METHOD THEREFOR | ORMDL3, OR51E2, STOM | RAB9A 1302/4885L3MBTL1 3197/4885NPC1 1191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.